Molecular imaging in gastroenterology has become more feasible with recent advances in imaging technology, molecular genetics, and next-generation biochemistry, in addition to advances in endoscopic imaging techniques including magnified high-resolution endoscopy, narrow band imaging or autofluorescence imaging, flexible spectral imaging color enhancement, and confocal laser endomicroscopy. These developments have the potential to serve as "red flag" techniques enabling the earlier and accurate detection of mucosal abnormalities (such as precancerous lesions) beyond biomarkers, virtual histology of detected lesions, and molecular targeted therapy-the strategy of "one stone to kill two or three birds"; however, more effort should be done to be "blue ocean" benefit. This review deals with the introduction of Raman spectroscopy endoscopy, imaging mass spectroscopy, and nanomolecule development for theranostics. Imaging of molecular pathological changes in cells/tissues/organs might open the "royal road" to either convincing diagnosis of diseases that otherwise would only be detected in the advanced stages or novel therapeutic methods targeted to personalized medicine.

Citations

Citations to this article as recorded by  

• A supramolecular colloidal system based on folate-conjugated β-cyclodextrin polymer and indocyanine green for enhanced tumor-targeted cell imaging in 2D culture and 3D tumor spheroids
  Yuting Wen, Jianfeng Wang, Wei Zheng, Jingling Zhu, Xia Song, Taili Chen, Miao Zhang, Zhiwei Huang, Jun Li
  Journal of Colloid and Interface Science.2024; 667: 259.     CrossRef
• ESR Position Paper on Imaging Biobanks
  
  Insights into Imaging.2015; 6(4): 403.     CrossRef
• International Digestive Endoscopy Network 2014: Turnpike to the Future
  Eun Young Kim, Kwang An Kwon, Il Ju Choi, Ji Kon Ryu, Ki Baik Hahm
  Clinical Endoscopy.2014; 47(5): 371.     CrossRef